Irritable Bowel Syndrome And Colorectal Cancer
Published on: October 2, 2024
irritable bowel syndrome and colorectal cancer featured image
Article author photo

Ayushi Vira

Masters of Clinical Research , Clinical research, <a href="https://www.sheffield.ac.uk/" rel="nofollow">The University of Sheffield</a>

Article reviewer photo

Shelja Chauhan

BAMS,PGDCR

What is Irritable Bowel Syndrome (IBS)?

Irritable bowel syndrome (IBS) is a collection of symptoms that occur simultaneously, including abdominal discomfort and changes in bowel motions, which might be diarrhoea, constipation, or both. IBS causes these symptoms without any apparent indicators of injury or disease in the digestive tract.

IBS is a functional gastrointestinal (GI) illness that doctors increasingly refer to as a disorder of gut-brain interactions. It is caused by issues with how your brain and gut communicate. These disorders make your gut more sensitive and alter how your intestinal muscles contract. If your gut is more sensitive, you may have increased abdominal discomfort and bloating. Changes in how the muscles in your intestine contract cause diarrhoea, constipation, or both.1

What is colorectal cancer (CRC)?

Colorectal cancer occurs when cells in the colon or rectum grow out of control. It is also known as "colon cancer." The colon is a big gut or bowel. The rectum is a canal that links the colon with the anus.2

Differences and similarities between the two disorders

Differential Diagnosis: 

  • IBS and CRC may have similar symptoms, such as stomach discomfort and changes in bowel habits. However, CRC symptoms are more chronic and increasing, whereas IBS symptoms vary over time.
  • Recognising the unique characteristics of each ailment is critical for correct diagnosis and prompt treatment. Disease progression to later stages with a worse prognosis might result from misdiagnosis or delayed detection of colorectal cancer.3,4

Screening and Surveillance: 

  • Differentiating between IBS and CRC is essential for effective screening and surveillance techniques. Individuals with IBS may not require routine screening for CRC, but those with worrying symptoms or risk factors may require further assessment to rule out CRC.
  • Healthcare practitioners must be aware of the risk factors and red flags that indicate CRC in patients with gastrointestinal symptoms, enabling  prompt referral for diagnostic investigation and intervention if necessary.3,4

Patient Education and Counselling:

  • Providing proper information regarding the distinctions between IBS and CRC is crucial for patient education and counselling. Patients with IBS may feel anxious or uncertain about their symptoms and might benefit from reassurance and education about their illness.
  • Patients must appreciate the need for symptom monitoring, adhering to approved screening recommendations, and seeking medical assistance if symptoms change or worsen, since they can aid in early identification and intervention for CRC.3,4

Understanding Irritable Bowel Syndrome (IBS)

IBS is determined by the appearance of your stools (poop) on days when you are experiencing symptom flare-ups. Most IBS patients have regular bowel motions on certain days but abnormal ones on others. The atypical days determine what type of IBS you have.

  • IBS with constipation (IBS-C): The majority of your stools are hard and lumpy.
  • IBS with diarrhoea (IBS-D): The majority of your stools are loose and watery.
  • IBS with mixed bowel habits (IBS-M): Your bowel motions are both hard and lumpy, as well as loose and watery.

The changes are significant. Some therapies are only effective for certain forms of IBS.5

Symptoms

The primary sign of IBS is discomfort or pain in the abdomen that is linked to a change in bowel movements. Constipation, cramps, bloating, distention, fullness, and even burning are some of the ways that IBS patients may express their discomfort in the abdomen. Emotional strain, certain meals consumed, the time after eating, constipation, or diarrhoea can all cause the discomfort. Additional symptoms include mucous in your stool (which might seem white), feeling like you can't empty your bowels after pooping.6

Diagnosis

  • Medical history and physical examination: Healthcare practitioners often begin the diagnosis procedure by acquiring a complete medical history, including symptoms, aggravating factors, and family history.
  • Symptom-based criteria: The Rome IV criteria are often used to diagnose IBS based on particular symptom patterns, such as abdominal pain or discomfort, related to changes in bowel habits, and present for at least three days per month in the previous three months.
  • Exclusion of other disorders: Since there are no particular diagnostic tests for IBS, healthcare practitioners may do diagnostic testing to rule out other gastrointestinal conditions that might resemble IBS symptoms, such as inflammatory bowel disease or celiac disease.
  • Further diagnostic testing: To further assess symptoms and rule out other conditions, medical professionals occasionally request additional testing. These tests might include breathalysers for bacterial overgrowth, blood tests, imaging studies (such as colonoscopies and flexible sigmoidoscopies), stool studies, or imaging studies.5,7

Treatment and management

  • Lifestyle adjustments, such as boosting fibre intake, avoiding trigger foods, and eating smaller,  frequent meals, can help ease symptoms.
  • Stress management: Because stress and psychological variables can aggravate IBS symptoms, stress reduction treatments such as relaxation exercises, mindfulness meditation, and cognitive-behavioural therapy may be useful.
  • Medication: Healthcare professionals may prescribe medication to treat particular symptoms of IBS based on the predominating symptoms and unique characteristics of each patient. Examples of such medications include laxatives or anti-diarrheal agents for bowel irregularities, low-dose antidepressants (like tricyclic antidepressants, and selective serotonin reuptake inhibitors) to improve bowel function and modulate pain perception, and antispasmodics (like dicyclomine, hyoscyamine) for abdominal pain.
  • Alternative therapies: Some people with IBS may benefit from probiotics, peppermint oil, acupuncture, or hypnosis. While evidence for the effectiveness of these therapies varies, they may be explored as supplementary treatments for symptom control in some individuals.1,5,7

Understanding Colorectal Cancer

Colorectal cancer often begins with polyps (a small clump of cells), which are growths on the inner lining of the colon or rectum. Although most polyps are benign, some, particularly adenomatous polyps, can develop into cancer over time. These adenomas are classified as precancerous, with tubular adenomas being the most prevalent kind. Villous adenomas, albeit less frequent, have a higher risk of developing cancer. Hyperplastic and inflammatory polyps are often not malignant, however big hyperplastic polyps may require careful monitoring. Sessile serrated polyps (SSP) and typical serrated adenomas (TSA) increase the chance of developing cancer. Polyp size, quantity, and histology (dysplasia) can all increase the risk of colorectal cancer. Regular screening and monitoring are critical for early discovery and management of these precancerous polyps, which can prevent colorectal cancer growth.9

Types of colorectal cancer

The rectum or the colon may be the site of colorectal cancer's onset. Colon cancer is a kind of cancer that originates in the colon. Rectal cancer refers to cancer that develops in the rectum.

The majority of colon and rectal cancers are adenocarcinoma, a kind of tumour that affects the cells lining the colon and rectum. This section is specifically about adenocarcinoma. Other forms of cancer that are less common but can start in the colon or rectum include neuroendocrine tumours of the gastrointestinal tract, gastrointestinal stromal tumour (GIST), small cell carcinoma, and lymphoma.10

Diagnosis

Early identification of colorectal cancer (CRC) is critical for better patient outcomes. Individuals over the age of 50 or at risk should undergo screenings such as faecal occult blood tests, colonoscopies, flexible sigmoidoscopies, and CT colonography. When CRC is suspected, further diagnostic procedures such as imaging scans and colonoscopies with biopsies are performed. 

Tumour markers and genetic testing help to track disease development and detect hereditary types. A multidisciplinary team of gastroenterologists, oncologists, surgeons, radiologists, and pathologists works together to guarantee correct diagnosis and staging. Histopathological study of biopsy samples identifies tumour features and informs treatment recommendations. 

Staging according to the TNM classification makes prognosis and therapy selection easier. A comprehensive diagnostic strategy that includes screening, imaging, biopsy, genetic testing, multidisciplinary teamwork, and staging is necessary for prompt intervention.14,4

Treatment Approaches

Surgery: It is still the primary treatment for colorectal cancer,  to remove the tumour completely and perhaps cure the patient. The procedures range from local excision for early-stage tumours to colectomy for more advanced instances. Minimally invasive methods, such as laparoscopy, are being used for speedier recovery and fewer problems.11

Chemotherapy: Chemotherapy is commonly used in conjunction with surgery to treat both localised and metastatic colorectal cancer. Fluorouracil (5-FU), leucovorin, oxaliplatin, and irinotecan are among the most common treatments. Targeted therapies, such as anti-EGFR and anti-VEGF medicines, are frequently used, especially for metastatic illness.12

Radiation treatment: Radiation treatment can be used to shrink tumours before surgery, to minimise local recurrence after surgery, or to relieve symptoms. Intensity-Modulated Radiation Therapy (IMRT) and Stereotactic Body Radiation Therapy (SBRT) are techniques that enable for precision tumour targeting while minimising harm to adjacent tissues.13

Summary

Irritable bowel syndrome (IBS) is a common digestive illness marked by stomach discomfort, bloating, and altered bowel patterns. The specific reason is unknown, although aberrant muscle contractions, gastrointestinal sensitivity, inflammation, and gut flora alterations all play a part. Triggers include specific meals, stress, and illnesses.

Diagnosis entails ruling out alternative possibilities based on symptoms and testing. The treatment focuses on symptom control through dietary changes, stress reduction, medicines, and lifestyle modifications. While IBS is a chronic condition, many people may effectively control their symptoms with therapy and lifestyle adjustments, which improves their quality of life. Regular communication with healthcare practitioners is essential for effective management.

Age, genetics, lifestyle, and past medical history are some of the risk factors for colorectal cancer, a common disease that affects the colon or rectum. Symptoms may include altered bowel habits, rectal bleeding, stomach pain, and unexplained weight loss. Screening tests and procedures such as colonoscopies are used to diagnose the condition, and treatment options include surgery, chemotherapy, and targeted therapies. Regular screening, a healthy lifestyle, and genetic counselling for high-risk individuals are all examples of preventive interventions. Overall, a thorough understanding and proactive actions are critical for successful colorectal cancer therapy and prevention. 

References

  1. Definition & Facts for Irritable Bowel Syndrome - NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases [Internet]. [cited 2024 Sep 26]. Available from: https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/definition-facts
  2. Colorectal cancer [Internet]. [cited 2024 May 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/colorectal-cancer
  3. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016 Feb 18;S0016-5085(16)00222-5.
  4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
  5. What Is Irritable Bowel Syndrome (IBS)? Cleveland Clinic [Internet]. [cited 2024 Sep 26]. Available from: https://my.clevelandclinic.org/health/diseases/4342-irritable-bowel-syndrome-ibs
  6. Irritable Bowel Syndrome(IBS) [Internet]. [cited 2024 May 6]. Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/irritable-bowel-syndrome-ibs
  7. Irritable bowel syndrome (IBS). nhs.uk [Internet]. 2017 [cited 2024 May 6]. Available from: https://www.nhs.uk/conditions/irritable-bowel-syndrome-ibs/
  8. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA A Cancer J Clinicians [Internet]. 2022 Jan [cited 2024 May 10];72(1):7–33. Available from: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21708
  9. What is colorectal cancer? | How Does Colorectal Cancer Start? [Internet]. [cited 2024 May 10]. Available from: https://www.cancer.org/cancer/types/colon-rectal-cancer/about/what-is-colorectal-cancer.html
  10. Types of Colorectal Cancer | SEER Training [Internet]. [cited 2024 May 10]. Available from: https://training.seer.cancer.gov/colorectal/intro/types.html
  11. Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B, et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg. 2015 Aug;221(2):415–23.
  12. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016 Aug;27(8):1386–422.
  13. Sun M, Moquet J, Ellender M, Bouffler S, Badie C, Baldwin-Cleland R, et al. Potential risks associated with the use of ionizing radiation for imaging and treatment of colorectal cancer in Lynch syndrome patients. Fam Cancer [Internet]. 2023 [cited 2024 May 10];22(1):61–70. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829596/
  14. National Comprehensive Cancer Network. (2022). NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf
Share

Ayushi Vira

Masters of Clinical Research , Clinical research, The University of Sheffield

Ayushi Vira is a clinical research professional with a strong pharmaceutical background, holding a degree from the University of Mumbai and an MSc in Clinical Research from the University of Sheffield. Her expertise spans drug safety analysis, data management, and patient recruitment, bolstered by certifications in Good Clinical Practice and Pharmacovigilance.

As a medical writer for Klarity and a researcher at the University of Sheffield, Ayushi has led discussion groups, published critical research findings, and conducted clinical trials. She excels in creating digital health content, data visualization, and enhancing patient recruitment strategies.

Fluent in several languages, Ayushi is dedicated to advancing the pharmaceutical industry through innovative research and effective patient engagement.Her dedication to these areas fulfils her passion to provide medical information that promotes global health.

arrow-right